Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of Maxigesic for reduction of opioid dose in IV PCA after laparoscopic gastrectomy
KCT0009934Phase 4Not yet recruiting
- Sponsor
- Kyongbo Pharm
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetaminophen + ibuprofen in postoperative pain, gastric cancer (GC), sponsored by Kyongbo Pharm. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
acetaminophen + ibuprofen
03
Conditions
postoperative paingastric cancer (GC)
Beyond the preview
Go deeper on KCT0009934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009934.